| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |